nodes	percent_of_prediction	percent_of_DWPC	metapath
Felbamate—CYP2E1—lung cancer	0.401	1	CbGaD
Felbamate—CYP2C19—Gefitinib—lung cancer	0.042	0.157	CbGbCtD
Felbamate—CYP2C19—Teniposide—lung cancer	0.0408	0.152	CbGbCtD
Felbamate—CYP2E1—Etoposide—lung cancer	0.0287	0.107	CbGbCtD
Felbamate—CYP3A4—Topotecan—lung cancer	0.0222	0.0829	CbGbCtD
Felbamate—CYP3A4—Gefitinib—lung cancer	0.0203	0.0759	CbGbCtD
Felbamate—CYP3A4—Teniposide—lung cancer	0.0197	0.0736	CbGbCtD
Felbamate—CYP3A4—Vinorelbine—lung cancer	0.0157	0.0584	CbGbCtD
Felbamate—CYP3A4—Crizotinib—lung cancer	0.0125	0.0465	CbGbCtD
Felbamate—CYP3A4—Erlotinib—lung cancer	0.012	0.0449	CbGbCtD
Felbamate—CYP3A4—Paclitaxel—lung cancer	0.011	0.0411	CbGbCtD
Felbamate—CYP3A4—Irinotecan—lung cancer	0.0109	0.0405	CbGbCtD
Felbamate—CYP3A4—Vinblastine—lung cancer	0.00965	0.036	CbGbCtD
Felbamate—CYP3A4—Etoposide—lung cancer	0.00869	0.0324	CbGbCtD
Felbamate—CYP3A4—Docetaxel—lung cancer	0.00795	0.0297	CbGbCtD
Felbamate—CYP3A4—Doxorubicin—lung cancer	0.00593	0.0221	CbGbCtD
Felbamate—Body temperature increased—Gemcitabine—lung cancer	8.17e-05	0.000335	CcSEcCtD
Felbamate—Rash—Vinorelbine—lung cancer	8.12e-05	0.000333	CcSEcCtD
Felbamate—Dermatitis—Vinorelbine—lung cancer	8.11e-05	0.000332	CcSEcCtD
Felbamate—Hypotension—Paclitaxel—lung cancer	8.09e-05	0.000332	CcSEcCtD
Felbamate—Headache—Vinorelbine—lung cancer	8.06e-05	0.000331	CcSEcCtD
Felbamate—Conjunctivitis—Methotrexate—lung cancer	8.06e-05	0.00033	CcSEcCtD
Felbamate—Dysphagia—Doxorubicin—lung cancer	8.05e-05	0.00033	CcSEcCtD
Felbamate—Asthma—Doxorubicin—lung cancer	8.05e-05	0.00033	CcSEcCtD
Felbamate—Leukopenia—Docetaxel—lung cancer	8.05e-05	0.00033	CcSEcCtD
Felbamate—Eosinophilia—Doxorubicin—lung cancer	7.97e-05	0.000327	CcSEcCtD
Felbamate—Sweating—Methotrexate—lung cancer	7.95e-05	0.000326	CcSEcCtD
Felbamate—Palpitations—Docetaxel—lung cancer	7.95e-05	0.000326	CcSEcCtD
Felbamate—Feeling abnormal—Cisplatin—lung cancer	7.94e-05	0.000326	CcSEcCtD
Felbamate—Paraesthesia—Etoposide—lung cancer	7.93e-05	0.000325	CcSEcCtD
Felbamate—Haematuria—Methotrexate—lung cancer	7.91e-05	0.000324	CcSEcCtD
Felbamate—Pancreatitis—Doxorubicin—lung cancer	7.9e-05	0.000324	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Paclitaxel—lung cancer	7.89e-05	0.000323	CcSEcCtD
Felbamate—Dyspnoea—Etoposide—lung cancer	7.87e-05	0.000323	CcSEcCtD
Felbamate—Somnolence—Etoposide—lung cancer	7.85e-05	0.000322	CcSEcCtD
Felbamate—Cough—Docetaxel—lung cancer	7.85e-05	0.000322	CcSEcCtD
Felbamate—Insomnia—Paclitaxel—lung cancer	7.83e-05	0.000321	CcSEcCtD
Felbamate—Epistaxis—Methotrexate—lung cancer	7.82e-05	0.000321	CcSEcCtD
Felbamate—Paraesthesia—Paclitaxel—lung cancer	7.77e-05	0.000319	CcSEcCtD
Felbamate—Hypertension—Docetaxel—lung cancer	7.76e-05	0.000318	CcSEcCtD
Felbamate—Agranulocytosis—Methotrexate—lung cancer	7.74e-05	0.000317	CcSEcCtD
Felbamate—Dyspnoea—Paclitaxel—lung cancer	7.72e-05	0.000316	CcSEcCtD
Felbamate—Somnolence—Paclitaxel—lung cancer	7.7e-05	0.000315	CcSEcCtD
Felbamate—Decreased appetite—Etoposide—lung cancer	7.68e-05	0.000315	CcSEcCtD
Felbamate—Arthralgia—Docetaxel—lung cancer	7.65e-05	0.000314	CcSEcCtD
Felbamate—Chest pain—Docetaxel—lung cancer	7.65e-05	0.000314	CcSEcCtD
Felbamate—Myalgia—Docetaxel—lung cancer	7.65e-05	0.000314	CcSEcCtD
Felbamate—Pancytopenia—Doxorubicin—lung cancer	7.65e-05	0.000313	CcSEcCtD
Felbamate—Nausea—Vinorelbine—lung cancer	7.65e-05	0.000313	CcSEcCtD
Felbamate—Dyspepsia—Paclitaxel—lung cancer	7.62e-05	0.000312	CcSEcCtD
Felbamate—Body temperature increased—Cisplatin—lung cancer	7.62e-05	0.000312	CcSEcCtD
Felbamate—Asthenia—Irinotecan—lung cancer	7.62e-05	0.000312	CcSEcCtD
Felbamate—Fatigue—Etoposide—lung cancer	7.61e-05	0.000312	CcSEcCtD
Felbamate—Pain—Etoposide—lung cancer	7.55e-05	0.000309	CcSEcCtD
Felbamate—Constipation—Etoposide—lung cancer	7.55e-05	0.000309	CcSEcCtD
Felbamate—Dysuria—Doxorubicin—lung cancer	7.53e-05	0.000309	CcSEcCtD
Felbamate—Decreased appetite—Paclitaxel—lung cancer	7.53e-05	0.000308	CcSEcCtD
Felbamate—Dry mouth—Docetaxel—lung cancer	7.49e-05	0.000307	CcSEcCtD
Felbamate—Upper respiratory tract infection—Doxorubicin—lung cancer	7.48e-05	0.000307	CcSEcCtD
Felbamate—Haemoglobin—Methotrexate—lung cancer	7.48e-05	0.000307	CcSEcCtD
Felbamate—Fatigue—Paclitaxel—lung cancer	7.46e-05	0.000306	CcSEcCtD
Felbamate—Haemorrhage—Methotrexate—lung cancer	7.44e-05	0.000305	CcSEcCtD
Felbamate—Hepatitis—Methotrexate—lung cancer	7.44e-05	0.000305	CcSEcCtD
Felbamate—Asthenia—Gemcitabine—lung cancer	7.42e-05	0.000304	CcSEcCtD
Felbamate—Pain—Paclitaxel—lung cancer	7.4e-05	0.000303	CcSEcCtD
Felbamate—Constipation—Paclitaxel—lung cancer	7.4e-05	0.000303	CcSEcCtD
Felbamate—Confusional state—Docetaxel—lung cancer	7.4e-05	0.000303	CcSEcCtD
Felbamate—Pharyngitis—Methotrexate—lung cancer	7.39e-05	0.000303	CcSEcCtD
Felbamate—Photosensitivity reaction—Doxorubicin—lung cancer	7.35e-05	0.000301	CcSEcCtD
Felbamate—Oedema—Docetaxel—lung cancer	7.34e-05	0.000301	CcSEcCtD
Felbamate—Anaphylactic shock—Docetaxel—lung cancer	7.34e-05	0.000301	CcSEcCtD
Felbamate—Weight increased—Doxorubicin—lung cancer	7.33e-05	0.0003	CcSEcCtD
Felbamate—Pruritus—Gemcitabine—lung cancer	7.32e-05	0.0003	CcSEcCtD
Felbamate—Infection—Docetaxel—lung cancer	7.29e-05	0.000299	CcSEcCtD
Felbamate—Weight decreased—Doxorubicin—lung cancer	7.29e-05	0.000299	CcSEcCtD
Felbamate—Feeling abnormal—Etoposide—lung cancer	7.28e-05	0.000298	CcSEcCtD
Felbamate—Hyperglycaemia—Doxorubicin—lung cancer	7.26e-05	0.000298	CcSEcCtD
Felbamate—Diarrhoea—Irinotecan—lung cancer	7.26e-05	0.000298	CcSEcCtD
Felbamate—Pneumonia—Doxorubicin—lung cancer	7.22e-05	0.000296	CcSEcCtD
Felbamate—Gastrointestinal pain—Etoposide—lung cancer	7.22e-05	0.000296	CcSEcCtD
Felbamate—Thrombocytopenia—Docetaxel—lung cancer	7.18e-05	0.000294	CcSEcCtD
Felbamate—Visual impairment—Methotrexate—lung cancer	7.17e-05	0.000294	CcSEcCtD
Felbamate—Tachycardia—Docetaxel—lung cancer	7.16e-05	0.000294	CcSEcCtD
Felbamate—Feeling abnormal—Paclitaxel—lung cancer	7.13e-05	0.000292	CcSEcCtD
Felbamate—Stevens-Johnson syndrome—Doxorubicin—lung cancer	7.12e-05	0.000292	CcSEcCtD
Felbamate—Gastrointestinal pain—Paclitaxel—lung cancer	7.08e-05	0.00029	CcSEcCtD
Felbamate—Diarrhoea—Gemcitabine—lung cancer	7.07e-05	0.00029	CcSEcCtD
Felbamate—Erythema multiforme—Methotrexate—lung cancer	7.04e-05	0.000289	CcSEcCtD
Felbamate—Dizziness—Irinotecan—lung cancer	7.02e-05	0.000288	CcSEcCtD
Felbamate—Urticaria—Etoposide—lung cancer	7.01e-05	0.000288	CcSEcCtD
Felbamate—Jaundice—Doxorubicin—lung cancer	7e-05	0.000287	CcSEcCtD
Felbamate—Anorexia—Docetaxel—lung cancer	6.99e-05	0.000287	CcSEcCtD
Felbamate—Body temperature increased—Etoposide—lung cancer	6.98e-05	0.000286	CcSEcCtD
Felbamate—Abdominal pain—Etoposide—lung cancer	6.98e-05	0.000286	CcSEcCtD
Felbamate—Urinary tract infection—Doxorubicin—lung cancer	6.98e-05	0.000286	CcSEcCtD
Felbamate—Conjunctivitis—Doxorubicin—lung cancer	6.98e-05	0.000286	CcSEcCtD
Felbamate—Asthenia—Cisplatin—lung cancer	6.92e-05	0.000283	CcSEcCtD
Felbamate—Sweating—Doxorubicin—lung cancer	6.88e-05	0.000282	CcSEcCtD
Felbamate—Urticaria—Paclitaxel—lung cancer	6.88e-05	0.000282	CcSEcCtD
Felbamate—Hypotension—Docetaxel—lung cancer	6.86e-05	0.000281	CcSEcCtD
Felbamate—Haematuria—Doxorubicin—lung cancer	6.85e-05	0.000281	CcSEcCtD
Felbamate—Abdominal pain—Paclitaxel—lung cancer	6.84e-05	0.000281	CcSEcCtD
Felbamate—Body temperature increased—Paclitaxel—lung cancer	6.84e-05	0.000281	CcSEcCtD
Felbamate—Epistaxis—Doxorubicin—lung cancer	6.77e-05	0.000278	CcSEcCtD
Felbamate—Vomiting—Irinotecan—lung cancer	6.75e-05	0.000277	CcSEcCtD
Felbamate—Sinusitis—Doxorubicin—lung cancer	6.74e-05	0.000276	CcSEcCtD
Felbamate—Agranulocytosis—Doxorubicin—lung cancer	6.7e-05	0.000275	CcSEcCtD
Felbamate—Rash—Irinotecan—lung cancer	6.69e-05	0.000274	CcSEcCtD
Felbamate—Dermatitis—Irinotecan—lung cancer	6.69e-05	0.000274	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Docetaxel—lung cancer	6.69e-05	0.000274	CcSEcCtD
Felbamate—Chills—Methotrexate—lung cancer	6.68e-05	0.000274	CcSEcCtD
Felbamate—Headache—Irinotecan—lung cancer	6.65e-05	0.000273	CcSEcCtD
Felbamate—Insomnia—Docetaxel—lung cancer	6.64e-05	0.000272	CcSEcCtD
Felbamate—Diarrhoea—Cisplatin—lung cancer	6.59e-05	0.00027	CcSEcCtD
Felbamate—Paraesthesia—Docetaxel—lung cancer	6.59e-05	0.00027	CcSEcCtD
Felbamate—Alopecia—Methotrexate—lung cancer	6.58e-05	0.00027	CcSEcCtD
Felbamate—Vomiting—Gemcitabine—lung cancer	6.57e-05	0.000269	CcSEcCtD
Felbamate—Bradycardia—Doxorubicin—lung cancer	6.56e-05	0.000269	CcSEcCtD
Felbamate—Dyspnoea—Docetaxel—lung cancer	6.54e-05	0.000268	CcSEcCtD
Felbamate—Somnolence—Docetaxel—lung cancer	6.52e-05	0.000267	CcSEcCtD
Felbamate—Rash—Gemcitabine—lung cancer	6.52e-05	0.000267	CcSEcCtD
Felbamate—Dermatitis—Gemcitabine—lung cancer	6.51e-05	0.000267	CcSEcCtD
Felbamate—Haemoglobin—Doxorubicin—lung cancer	6.48e-05	0.000266	CcSEcCtD
Felbamate—Headache—Gemcitabine—lung cancer	6.48e-05	0.000266	CcSEcCtD
Felbamate—Rhinitis—Doxorubicin—lung cancer	6.46e-05	0.000265	CcSEcCtD
Felbamate—Dyspepsia—Docetaxel—lung cancer	6.46e-05	0.000265	CcSEcCtD
Felbamate—Haemorrhage—Doxorubicin—lung cancer	6.45e-05	0.000264	CcSEcCtD
Felbamate—Hepatitis—Doxorubicin—lung cancer	6.45e-05	0.000264	CcSEcCtD
Felbamate—Pharyngitis—Doxorubicin—lung cancer	6.4e-05	0.000262	CcSEcCtD
Felbamate—Decreased appetite—Docetaxel—lung cancer	6.38e-05	0.000261	CcSEcCtD
Felbamate—Dysgeusia—Methotrexate—lung cancer	6.35e-05	0.00026	CcSEcCtD
Felbamate—Asthenia—Etoposide—lung cancer	6.34e-05	0.00026	CcSEcCtD
Felbamate—Fatigue—Docetaxel—lung cancer	6.33e-05	0.000259	CcSEcCtD
Felbamate—Nausea—Irinotecan—lung cancer	6.31e-05	0.000258	CcSEcCtD
Felbamate—Constipation—Docetaxel—lung cancer	6.28e-05	0.000257	CcSEcCtD
Felbamate—Pain—Docetaxel—lung cancer	6.28e-05	0.000257	CcSEcCtD
Felbamate—Pruritus—Etoposide—lung cancer	6.25e-05	0.000256	CcSEcCtD
Felbamate—Visual impairment—Doxorubicin—lung cancer	6.21e-05	0.000255	CcSEcCtD
Felbamate—Asthenia—Paclitaxel—lung cancer	6.21e-05	0.000255	CcSEcCtD
Felbamate—Nausea—Gemcitabine—lung cancer	6.14e-05	0.000252	CcSEcCtD
Felbamate—Vomiting—Cisplatin—lung cancer	6.13e-05	0.000251	CcSEcCtD
Felbamate—Pruritus—Paclitaxel—lung cancer	6.13e-05	0.000251	CcSEcCtD
Felbamate—Erythema multiforme—Doxorubicin—lung cancer	6.09e-05	0.00025	CcSEcCtD
Felbamate—Rash—Cisplatin—lung cancer	6.08e-05	0.000249	CcSEcCtD
Felbamate—Dermatitis—Cisplatin—lung cancer	6.07e-05	0.000249	CcSEcCtD
Felbamate—Feeling abnormal—Docetaxel—lung cancer	6.05e-05	0.000248	CcSEcCtD
Felbamate—Diarrhoea—Etoposide—lung cancer	6.04e-05	0.000248	CcSEcCtD
Felbamate—Ill-defined disorder—Methotrexate—lung cancer	6.01e-05	0.000246	CcSEcCtD
Felbamate—Gastrointestinal pain—Docetaxel—lung cancer	6e-05	0.000246	CcSEcCtD
Felbamate—Anaemia—Methotrexate—lung cancer	5.99e-05	0.000246	CcSEcCtD
Felbamate—Flushing—Doxorubicin—lung cancer	5.98e-05	0.000245	CcSEcCtD
Felbamate—Diarrhoea—Paclitaxel—lung cancer	5.92e-05	0.000243	CcSEcCtD
Felbamate—Malaise—Methotrexate—lung cancer	5.84e-05	0.00024	CcSEcCtD
Felbamate—Dizziness—Etoposide—lung cancer	5.84e-05	0.000239	CcSEcCtD
Felbamate—Abdominal pain—Docetaxel—lung cancer	5.8e-05	0.000238	CcSEcCtD
Felbamate—Body temperature increased—Docetaxel—lung cancer	5.8e-05	0.000238	CcSEcCtD
Felbamate—Leukopenia—Methotrexate—lung cancer	5.8e-05	0.000238	CcSEcCtD
Felbamate—Chills—Doxorubicin—lung cancer	5.78e-05	0.000237	CcSEcCtD
Felbamate—Dizziness—Paclitaxel—lung cancer	5.72e-05	0.000235	CcSEcCtD
Felbamate—Nausea—Cisplatin—lung cancer	5.72e-05	0.000235	CcSEcCtD
Felbamate—GRIN2B—BDNF signaling pathway—HRAS—lung cancer	5.71e-05	0.000659	CbGpPWpGaD
Felbamate—Alopecia—Doxorubicin—lung cancer	5.7e-05	0.000233	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—FGFR1—lung cancer	5.68e-05	0.000655	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—GSTA1—lung cancer	5.67e-05	0.000654	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—CYP1A1—lung cancer	5.66e-05	0.000653	CbGpPWpGaD
Felbamate—Cough—Methotrexate—lung cancer	5.65e-05	0.000232	CcSEcCtD
Felbamate—Vomiting—Etoposide—lung cancer	5.61e-05	0.00023	CcSEcCtD
Felbamate—CYP2E1—Metapathway biotransformation—CYP1A1—lung cancer	5.58e-05	0.000644	CbGpPWpGaD
Felbamate—Rash—Etoposide—lung cancer	5.57e-05	0.000228	CcSEcCtD
Felbamate—Dermatitis—Etoposide—lung cancer	5.56e-05	0.000228	CcSEcCtD
Felbamate—Headache—Etoposide—lung cancer	5.53e-05	0.000227	CcSEcCtD
Felbamate—Flatulence—Doxorubicin—lung cancer	5.53e-05	0.000227	CcSEcCtD
Felbamate—Myalgia—Methotrexate—lung cancer	5.52e-05	0.000226	CcSEcCtD
Felbamate—Chest pain—Methotrexate—lung cancer	5.52e-05	0.000226	CcSEcCtD
Felbamate—Arthralgia—Methotrexate—lung cancer	5.52e-05	0.000226	CcSEcCtD
Felbamate—Tension—Doxorubicin—lung cancer	5.51e-05	0.000226	CcSEcCtD
Felbamate—Vomiting—Paclitaxel—lung cancer	5.5e-05	0.000226	CcSEcCtD
Felbamate—Dysgeusia—Doxorubicin—lung cancer	5.5e-05	0.000225	CcSEcCtD
Felbamate—Rash—Paclitaxel—lung cancer	5.46e-05	0.000224	CcSEcCtD
Felbamate—Dermatitis—Paclitaxel—lung cancer	5.45e-05	0.000224	CcSEcCtD
Felbamate—Discomfort—Methotrexate—lung cancer	5.45e-05	0.000223	CcSEcCtD
Felbamate—Nervousness—Doxorubicin—lung cancer	5.45e-05	0.000223	CcSEcCtD
Felbamate—Headache—Paclitaxel—lung cancer	5.42e-05	0.000222	CcSEcCtD
Felbamate—GRIN2B—Axon guidance—RAF1—lung cancer	5.42e-05	0.000625	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—ERBB2—lung cancer	5.36e-05	0.000618	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	5.36e-05	0.000618	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—KDR—lung cancer	5.35e-05	0.000617	CbGpPWpGaD
Felbamate—Confusional state—Methotrexate—lung cancer	5.33e-05	0.000219	CcSEcCtD
Felbamate—Anaphylactic shock—Methotrexate—lung cancer	5.29e-05	0.000217	CcSEcCtD
Felbamate—CYP3A4—Biological oxidations—UGT1A1—lung cancer	5.28e-05	0.000608	CbGpPWpGaD
Felbamate—Asthenia—Docetaxel—lung cancer	5.26e-05	0.000216	CcSEcCtD
Felbamate—Infection—Methotrexate—lung cancer	5.25e-05	0.000215	CcSEcCtD
Felbamate—Nausea—Etoposide—lung cancer	5.24e-05	0.000215	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—MET—lung cancer	5.24e-05	0.000604	CbGpPWpGaD
Felbamate—Ill-defined disorder—Doxorubicin—lung cancer	5.21e-05	0.000213	CcSEcCtD
Felbamate—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	5.2e-05	0.0006	CbGpPWpGaD
Felbamate—Pruritus—Docetaxel—lung cancer	5.19e-05	0.000213	CcSEcCtD
Felbamate—Anaemia—Doxorubicin—lung cancer	5.19e-05	0.000213	CcSEcCtD
Felbamate—Thrombocytopenia—Methotrexate—lung cancer	5.18e-05	0.000212	CcSEcCtD
Felbamate—GRIN2A—Transmission across Chemical Synapses—HRAS—lung cancer	5.16e-05	0.000596	CbGpPWpGaD
Felbamate—Agitation—Doxorubicin—lung cancer	5.16e-05	0.000211	CcSEcCtD
Felbamate—Nausea—Paclitaxel—lung cancer	5.14e-05	0.000211	CcSEcCtD
Felbamate—Hyperhidrosis—Methotrexate—lung cancer	5.11e-05	0.00021	CcSEcCtD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	5.09e-05	0.000586	CbGpPWpGaD
Felbamate—Malaise—Doxorubicin—lung cancer	5.06e-05	0.000207	CcSEcCtD
Felbamate—GRIN2B—BDNF signaling pathway—AKT1—lung cancer	5.04e-05	0.000581	CbGpPWpGaD
Felbamate—Anorexia—Methotrexate—lung cancer	5.04e-05	0.000207	CcSEcCtD
Felbamate—Leukopenia—Doxorubicin—lung cancer	5.02e-05	0.000206	CcSEcCtD
Felbamate—Diarrhoea—Docetaxel—lung cancer	5.02e-05	0.000206	CcSEcCtD
Felbamate—CYP2C19—Biological oxidations—GSTP1—lung cancer	5.02e-05	0.000578	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—AZIN2—lung cancer	4.98e-05	0.000574	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—COL4A3BP—lung cancer	4.98e-05	0.000574	CbGpPWpGaD
Felbamate—Palpitations—Doxorubicin—lung cancer	4.96e-05	0.000203	CcSEcCtD
Felbamate—CYP2C19—Metapathway biotransformation—GSTP1—lung cancer	4.95e-05	0.00057	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	4.95e-05	0.00057	CbGpPWpGaD
Felbamate—Hypotension—Methotrexate—lung cancer	4.94e-05	0.000203	CcSEcCtD
Felbamate—Cough—Doxorubicin—lung cancer	4.9e-05	0.000201	CcSEcCtD
Felbamate—Dizziness—Docetaxel—lung cancer	4.85e-05	0.000199	CcSEcCtD
Felbamate—Hypertension—Doxorubicin—lung cancer	4.84e-05	0.000199	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Methotrexate—lung cancer	4.82e-05	0.000198	CcSEcCtD
Felbamate—Insomnia—Methotrexate—lung cancer	4.78e-05	0.000196	CcSEcCtD
Felbamate—Myalgia—Doxorubicin—lung cancer	4.78e-05	0.000196	CcSEcCtD
Felbamate—Arthralgia—Doxorubicin—lung cancer	4.78e-05	0.000196	CcSEcCtD
Felbamate—Chest pain—Doxorubicin—lung cancer	4.78e-05	0.000196	CcSEcCtD
Felbamate—Anxiety—Doxorubicin—lung cancer	4.76e-05	0.000195	CcSEcCtD
Felbamate—Paraesthesia—Methotrexate—lung cancer	4.75e-05	0.000195	CcSEcCtD
Felbamate—Discomfort—Doxorubicin—lung cancer	4.72e-05	0.000193	CcSEcCtD
Felbamate—Dyspnoea—Methotrexate—lung cancer	4.72e-05	0.000193	CcSEcCtD
Felbamate—Somnolence—Methotrexate—lung cancer	4.7e-05	0.000193	CcSEcCtD
Felbamate—Dry mouth—Doxorubicin—lung cancer	4.67e-05	0.000192	CcSEcCtD
Felbamate—Vomiting—Docetaxel—lung cancer	4.67e-05	0.000191	CcSEcCtD
Felbamate—Dyspepsia—Methotrexate—lung cancer	4.66e-05	0.000191	CcSEcCtD
Felbamate—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	4.65e-05	0.000537	CbGpPWpGaD
Felbamate—Rash—Docetaxel—lung cancer	4.63e-05	0.00019	CcSEcCtD
Felbamate—Dermatitis—Docetaxel—lung cancer	4.62e-05	0.000189	CcSEcCtD
Felbamate—Confusional state—Doxorubicin—lung cancer	4.62e-05	0.000189	CcSEcCtD
Felbamate—CYP2C19—Biological oxidations—GSTM1—lung cancer	4.61e-05	0.000531	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—MMP9—lung cancer	4.6e-05	0.000531	CbGpPWpGaD
Felbamate—Decreased appetite—Methotrexate—lung cancer	4.6e-05	0.000188	CcSEcCtD
Felbamate—Headache—Docetaxel—lung cancer	4.6e-05	0.000188	CcSEcCtD
Felbamate—Oedema—Doxorubicin—lung cancer	4.58e-05	0.000188	CcSEcCtD
Felbamate—Anaphylactic shock—Doxorubicin—lung cancer	4.58e-05	0.000188	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—IL6R—lung cancer	4.58e-05	0.000528	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—CREBBP—lung cancer	4.57e-05	0.000527	CbGpPWpGaD
Felbamate—Fatigue—Methotrexate—lung cancer	4.56e-05	0.000187	CcSEcCtD
Felbamate—Infection—Doxorubicin—lung cancer	4.55e-05	0.000186	CcSEcCtD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	4.55e-05	0.000525	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—GSTM1—lung cancer	4.55e-05	0.000524	CbGpPWpGaD
Felbamate—Pain—Methotrexate—lung cancer	4.52e-05	0.000185	CcSEcCtD
Felbamate—CYP3A4—Biological oxidations—HPGDS—lung cancer	4.49e-05	0.000517	CbGpPWpGaD
Felbamate—Thrombocytopenia—Doxorubicin—lung cancer	4.48e-05	0.000184	CcSEcCtD
Felbamate—Tachycardia—Doxorubicin—lung cancer	4.47e-05	0.000183	CcSEcCtD
Felbamate—Hyperhidrosis—Doxorubicin—lung cancer	4.43e-05	0.000181	CcSEcCtD
Felbamate—GRIN2B—Transmission across Chemical Synapses—HRAS—lung cancer	4.39e-05	0.000506	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—CYP1A1—lung cancer	4.37e-05	0.000504	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MMP2—lung cancer	4.37e-05	0.000504	CbGpPWpGaD
Felbamate—Anorexia—Doxorubicin—lung cancer	4.37e-05	0.000179	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—MAP2K1—lung cancer	4.36e-05	0.000503	CbGpPWpGaD
Felbamate—Nausea—Docetaxel—lung cancer	4.36e-05	0.000179	CcSEcCtD
Felbamate—Feeling abnormal—Methotrexate—lung cancer	4.36e-05	0.000179	CcSEcCtD
Felbamate—CYP3A4—Biological oxidations—GSTT1—lung cancer	4.35e-05	0.000502	CbGpPWpGaD
Felbamate—Gastrointestinal pain—Methotrexate—lung cancer	4.32e-05	0.000177	CcSEcCtD
Felbamate—CYP2C19—Metapathway biotransformation—CYP1A1—lung cancer	4.31e-05	0.000497	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—GCLC—lung cancer	4.3e-05	0.000496	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—CYP2A6—lung cancer	4.3e-05	0.000496	CbGpPWpGaD
Felbamate—Hypotension—Doxorubicin—lung cancer	4.28e-05	0.000175	CcSEcCtD
Felbamate—GRIN2B—Axon guidance—SRC—lung cancer	4.24e-05	0.000489	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ATP5H—lung cancer	4.24e-05	0.000488	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—POMC—lung cancer	4.22e-05	0.000487	CbGpPWpGaD
Felbamate—Urticaria—Methotrexate—lung cancer	4.2e-05	0.000172	CcSEcCtD
Felbamate—Body temperature increased—Methotrexate—lung cancer	4.18e-05	0.000171	CcSEcCtD
Felbamate—Abdominal pain—Methotrexate—lung cancer	4.18e-05	0.000171	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Doxorubicin—lung cancer	4.17e-05	0.000171	CcSEcCtD
Felbamate—Insomnia—Doxorubicin—lung cancer	4.14e-05	0.00017	CcSEcCtD
Felbamate—GRIN2B—Axon guidance—VEGFA—lung cancer	4.13e-05	0.000476	CbGpPWpGaD
Felbamate—Paraesthesia—Doxorubicin—lung cancer	4.11e-05	0.000169	CcSEcCtD
Felbamate—Dyspnoea—Doxorubicin—lung cancer	4.08e-05	0.000167	CcSEcCtD
Felbamate—GRIN2B—Axon guidance—NRAS—lung cancer	4.08e-05	0.000471	CbGpPWpGaD
Felbamate—Somnolence—Doxorubicin—lung cancer	4.07e-05	0.000167	CcSEcCtD
Felbamate—Dyspepsia—Doxorubicin—lung cancer	4.03e-05	0.000165	CcSEcCtD
Felbamate—Decreased appetite—Doxorubicin—lung cancer	3.98e-05	0.000163	CcSEcCtD
Felbamate—GRIN2A—Neuronal System—HRAS—lung cancer	3.96e-05	0.000456	CbGpPWpGaD
Felbamate—Fatigue—Doxorubicin—lung cancer	3.95e-05	0.000162	CcSEcCtD
Felbamate—Constipation—Doxorubicin—lung cancer	3.92e-05	0.000161	CcSEcCtD
Felbamate—Pain—Doxorubicin—lung cancer	3.92e-05	0.000161	CcSEcCtD
Felbamate—GRIN2B—Axon guidance—MAPK3—lung cancer	3.91e-05	0.000451	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—RAF1—lung cancer	3.87e-05	0.000446	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—AZIN2—lung cancer	3.84e-05	0.000443	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—COL4A3BP—lung cancer	3.84e-05	0.000443	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—ERBB2—lung cancer	3.83e-05	0.000441	CbGpPWpGaD
Felbamate—Asthenia—Methotrexate—lung cancer	3.79e-05	0.000156	CcSEcCtD
Felbamate—CYP2E1—Metabolism—PLBD1—lung cancer	3.77e-05	0.000435	CbGpPWpGaD
Felbamate—Feeling abnormal—Doxorubicin—lung cancer	3.77e-05	0.000155	CcSEcCtD
Felbamate—Gastrointestinal pain—Doxorubicin—lung cancer	3.74e-05	0.000153	CcSEcCtD
Felbamate—Pruritus—Methotrexate—lung cancer	3.74e-05	0.000153	CcSEcCtD
Felbamate—GRIN2B—Axon guidance—EGFR—lung cancer	3.72e-05	0.000429	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	3.69e-05	0.000425	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—CYP2E1—lung cancer	3.66e-05	0.000422	CbGpPWpGaD
Felbamate—Urticaria—Doxorubicin—lung cancer	3.64e-05	0.000149	CcSEcCtD
Felbamate—Abdominal pain—Doxorubicin—lung cancer	3.62e-05	0.000148	CcSEcCtD
Felbamate—Body temperature increased—Doxorubicin—lung cancer	3.62e-05	0.000148	CcSEcCtD
Felbamate—Diarrhoea—Methotrexate—lung cancer	3.62e-05	0.000148	CcSEcCtD
Felbamate—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	3.61e-05	0.000416	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	3.58e-05	0.000413	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—KRAS—lung cancer	3.51e-05	0.000405	CbGpPWpGaD
Felbamate—Dizziness—Methotrexate—lung cancer	3.5e-05	0.000143	CcSEcCtD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	3.47e-05	0.0004	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—HSD17B10—lung cancer	3.45e-05	0.000398	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—HRAS—lung cancer	3.36e-05	0.000388	CbGpPWpGaD
Felbamate—Vomiting—Methotrexate—lung cancer	3.36e-05	0.000138	CcSEcCtD
Felbamate—Rash—Methotrexate—lung cancer	3.33e-05	0.000137	CcSEcCtD
Felbamate—Dermatitis—Methotrexate—lung cancer	3.33e-05	0.000137	CcSEcCtD
Felbamate—Headache—Methotrexate—lung cancer	3.31e-05	0.000136	CcSEcCtD
Felbamate—Asthenia—Doxorubicin—lung cancer	3.29e-05	0.000135	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—MMP9—lung cancer	3.28e-05	0.000379	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ATP5H—lung cancer	3.27e-05	0.000377	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—POMC—lung cancer	3.26e-05	0.000376	CbGpPWpGaD
Felbamate—Pruritus—Doxorubicin—lung cancer	3.24e-05	0.000133	CcSEcCtD
Felbamate—CYP2E1—Metabolism—CKB—lung cancer	3.21e-05	0.00037	CbGpPWpGaD
Felbamate—Nausea—Methotrexate—lung cancer	3.14e-05	0.000129	CcSEcCtD
Felbamate—Diarrhoea—Doxorubicin—lung cancer	3.13e-05	0.000128	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—EP300—lung cancer	3.11e-05	0.000359	CbGpPWpGaD
Felbamate—Dizziness—Doxorubicin—lung cancer	3.03e-05	0.000124	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—SRC—lung cancer	3.03e-05	0.000349	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CNDP2—lung cancer	3.02e-05	0.000348	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTM2—lung cancer	3.02e-05	0.000348	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—GSTP1—lung cancer	3.02e-05	0.000348	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	3e-05	0.000346	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—HRAS—lung cancer	2.99e-05	0.000344	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	2.97e-05	0.000343	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—VEGFA—lung cancer	2.95e-05	0.00034	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—MTMR3—lung cancer	2.94e-05	0.000339	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—STAT3—lung cancer	2.92e-05	0.000337	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PLBD1—lung cancer	2.91e-05	0.000336	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—NRAS—lung cancer	2.91e-05	0.000336	CbGpPWpGaD
Felbamate—Vomiting—Doxorubicin—lung cancer	2.91e-05	0.000119	CcSEcCtD
Felbamate—Rash—Doxorubicin—lung cancer	2.89e-05	0.000118	CcSEcCtD
Felbamate—Dermatitis—Doxorubicin—lung cancer	2.88e-05	0.000118	CcSEcCtD
Felbamate—Headache—Doxorubicin—lung cancer	2.87e-05	0.000118	CcSEcCtD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	2.86e-05	0.00033	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PGAM1—lung cancer	2.86e-05	0.00033	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—IL6—lung cancer	2.86e-05	0.000329	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MAPK3—lung cancer	2.79e-05	0.000322	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—GSTM1—lung cancer	2.77e-05	0.00032	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	2.73e-05	0.000315	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP2A7—lung cancer	2.73e-05	0.000315	CbGpPWpGaD
Felbamate—Nausea—Doxorubicin—lung cancer	2.72e-05	0.000111	CcSEcCtD
Felbamate—CYP2E1—Metabolism—SDC4—lung cancer	2.67e-05	0.000308	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—HSD17B10—lung cancer	2.66e-05	0.000307	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—EGFR—lung cancer	2.65e-05	0.000306	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—CYP1A1—lung cancer	2.63e-05	0.000303	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	2.59e-05	0.000299	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—KRAS—lung cancer	2.51e-05	0.000289	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CKB—lung cancer	2.48e-05	0.000286	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—RRM1—lung cancer	2.43e-05	0.00028	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTA3—lung cancer	2.43e-05	0.00028	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CNDP2—lung cancer	2.33e-05	0.000268	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTM2—lung cancer	2.33e-05	0.000268	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—COL4A3BP—lung cancer	2.31e-05	0.000266	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—AZIN2—lung cancer	2.31e-05	0.000266	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—B4GALT5—lung cancer	2.29e-05	0.000264	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—MTMR3—lung cancer	2.26e-05	0.000261	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTA4—lung cancer	2.22e-05	0.000257	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PGAM1—lung cancer	2.21e-05	0.000255	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTA2—lung cancer	2.17e-05	0.00025	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—HRAS—lung cancer	2.13e-05	0.000246	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP2A7—lung cancer	2.11e-05	0.000243	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTA1—lung cancer	2.09e-05	0.000241	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ABCC3—lung cancer	2.07e-05	0.000238	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SDC4—lung cancer	2.06e-05	0.000238	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—IL6—lung cancer	2.04e-05	0.000235	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—AKR1C1—lung cancer	2e-05	0.000231	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ATP5H—lung cancer	1.96e-05	0.000227	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—POMC—lung cancer	1.96e-05	0.000226	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—UGT1A1—lung cancer	1.94e-05	0.000224	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—AKT1—lung cancer	1.88e-05	0.000217	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—RRM1—lung cancer	1.88e-05	0.000216	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTA3—lung cancer	1.88e-05	0.000216	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GNG11—lung cancer	1.88e-05	0.000216	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ALDOA—lung cancer	1.79e-05	0.000206	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—B4GALT5—lung cancer	1.76e-05	0.000203	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PLBD1—lung cancer	1.75e-05	0.000202	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—NCOA3—lung cancer	1.73e-05	0.0002	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTA4—lung cancer	1.72e-05	0.000198	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ADCY1—lung cancer	1.69e-05	0.000194	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ABCG2—lung cancer	1.69e-05	0.000194	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.68e-05	0.000193	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTA2—lung cancer	1.67e-05	0.000193	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—HPGDS—lung cancer	1.65e-05	0.000191	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ENO2—lung cancer	1.65e-05	0.000191	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PPP2R1B—lung cancer	1.64e-05	0.000189	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTA1—lung cancer	1.61e-05	0.000186	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTT1—lung cancer	1.6e-05	0.000185	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—HSD17B10—lung cancer	1.6e-05	0.000185	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ABCC3—lung cancer	1.6e-05	0.000184	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GCLC—lung cancer	1.59e-05	0.000183	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP2A6—lung cancer	1.59e-05	0.000183	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—AKR1C1—lung cancer	1.55e-05	0.000178	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ENO1—lung cancer	1.5e-05	0.000173	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—UGT1A1—lung cancer	1.5e-05	0.000173	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CKB—lung cancer	1.49e-05	0.000172	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GNG11—lung cancer	1.45e-05	0.000167	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.44e-05	0.000166	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTM2—lung cancer	1.4e-05	0.000161	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CNDP2—lung cancer	1.4e-05	0.000161	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ALDOA—lung cancer	1.38e-05	0.000159	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—MTMR3—lung cancer	1.36e-05	0.000157	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—NCOA3—lung cancer	1.34e-05	0.000154	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—NQO1—lung cancer	1.33e-05	0.000154	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PGAM1—lung cancer	1.33e-05	0.000153	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.31e-05	0.000152	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ADCY1—lung cancer	1.3e-05	0.00015	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ABCG2—lung cancer	1.3e-05	0.00015	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—HPGDS—lung cancer	1.28e-05	0.000147	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ENO2—lung cancer	1.28e-05	0.000147	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PPP2R1B—lung cancer	1.27e-05	0.000146	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP2A7—lung cancer	1.27e-05	0.000146	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.25e-05	0.000144	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SDC4—lung cancer	1.24e-05	0.000143	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTT1—lung cancer	1.24e-05	0.000143	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GCLC—lung cancer	1.22e-05	0.000141	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP2A6—lung cancer	1.22e-05	0.000141	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.22e-05	0.00014	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—STK11—lung cancer	1.2e-05	0.000139	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ENO1—lung cancer	1.16e-05	0.000134	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.16e-05	0.000133	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.14e-05	0.000131	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—RRM1—lung cancer	1.13e-05	0.00013	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTA3—lung cancer	1.13e-05	0.00013	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTP1—lung cancer	1.11e-05	0.000128	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CAT—lung cancer	1.08e-05	0.000125	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—B4GALT5—lung cancer	1.06e-05	0.000122	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ABCB1—lung cancer	1.05e-05	0.000121	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP2E1—lung cancer	1.04e-05	0.00012	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—TYMS—lung cancer	1.03e-05	0.000119	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTA4—lung cancer	1.03e-05	0.000119	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—NQO1—lung cancer	1.03e-05	0.000119	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTM1—lung cancer	1.02e-05	0.000118	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.01e-05	0.000116	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTA2—lung cancer	1.01e-05	0.000116	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	9.98e-06	0.000115	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTA1—lung cancer	9.7e-06	0.000112	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP1A1—lung cancer	9.68e-06	0.000112	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ERCC2—lung cancer	9.6e-06	0.000111	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ABCC3—lung cancer	9.6e-06	0.000111	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—AKR1C1—lung cancer	9.29e-06	0.000107	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—STK11—lung cancer	9.27e-06	0.000107	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—UGT1A1—lung cancer	9.02e-06	0.000104	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.7e-06	0.0001	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GNG11—lung cancer	8.7e-06	0.0001	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTP1—lung cancer	8.58e-06	9.89e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CAT—lung cancer	8.35e-06	9.62e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—APOA1—lung cancer	8.31e-06	9.58e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	8.3e-06	9.57e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ALDOA—lung cancer	8.28e-06	9.55e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ABCB1—lung cancer	8.12e-06	9.36e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—NCOA3—lung cancer	8.04e-06	9.27e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—TYMS—lung cancer	7.97e-06	9.19e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTM1—lung cancer	7.88e-06	9.09e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ADCY1—lung cancer	7.82e-06	9.02e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ABCG2—lung cancer	7.82e-06	9.02e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—HPGDS—lung cancer	7.67e-06	8.85e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ENO2—lung cancer	7.67e-06	8.85e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PPP2R1B—lung cancer	7.62e-06	8.79e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CG—lung cancer	7.59e-06	8.75e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP1A1—lung cancer	7.47e-06	8.62e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTT1—lung cancer	7.44e-06	8.58e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ERCC2—lung cancer	7.41e-06	8.54e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP2A6—lung cancer	7.35e-06	8.48e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GCLC—lung cancer	7.35e-06	8.48e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—POMC—lung cancer	7.22e-06	8.33e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CREBBP—lung cancer	7.03e-06	8.11e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ENO1—lung cancer	6.97e-06	8.04e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CD—lung cancer	6.67e-06	7.69e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ALB—lung cancer	6.58e-06	7.59e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—APOA1—lung cancer	6.41e-06	7.39e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP2E1—lung cancer	6.25e-06	7.21e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—NQO1—lung cancer	6.18e-06	7.13e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6.14e-06	7.08e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CG—lung cancer	5.85e-06	6.75e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CB—lung cancer	5.81e-06	6.7e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PTGS2—lung cancer	5.76e-06	6.64e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—STK11—lung cancer	5.57e-06	6.43e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—POMC—lung cancer	5.57e-06	6.42e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CREBBP—lung cancer	5.43e-06	6.26e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTP1—lung cancer	5.16e-06	5.95e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CD—lung cancer	5.14e-06	5.93e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ALB—lung cancer	5.08e-06	5.86e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PTEN—lung cancer	5.02e-06	5.79e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CAT—lung cancer	5.02e-06	5.79e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ABCB1—lung cancer	4.88e-06	5.63e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—TYMS—lung cancer	4.79e-06	5.53e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—EP300—lung cancer	4.79e-06	5.52e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTM1—lung cancer	4.74e-06	5.46e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP1A1—lung cancer	4.49e-06	5.18e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CB—lung cancer	4.48e-06	5.17e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ERCC2—lung cancer	4.46e-06	5.14e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PTGS2—lung cancer	4.44e-06	5.12e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PTEN—lung cancer	3.87e-06	4.47e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—APOA1—lung cancer	3.85e-06	4.44e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—EP300—lung cancer	3.7e-06	4.26e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CA—lung cancer	3.54e-06	4.09e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CG—lung cancer	3.52e-06	4.06e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—POMC—lung cancer	3.35e-06	3.86e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CREBBP—lung cancer	3.26e-06	3.76e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CD—lung cancer	3.09e-06	3.57e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ALB—lung cancer	3.05e-06	3.52e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—AKT1—lung cancer	2.89e-06	3.34e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CA—lung cancer	2.73e-06	3.15e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CB—lung cancer	2.7e-06	3.11e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PTGS2—lung cancer	2.67e-06	3.08e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PTEN—lung cancer	2.33e-06	2.69e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—AKT1—lung cancer	2.23e-06	2.58e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—EP300—lung cancer	2.22e-06	2.56e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CA—lung cancer	1.64e-06	1.9e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—AKT1—lung cancer	1.34e-06	1.55e-05	CbGpPWpGaD
